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Introduction
Fragile X syndrome is the most common form of fami-
lial mental retardation. The carrier rate is 1/165 to
1/1,540 [1,2] and the occurrence of the full mutation
is 1/1,000 to 1/4,000 in males and 1/2,000 to 1/9,000
in females [1,3]. The etiology is known to be an unstable
gene, FMR1, on the X chromosome caused by a series
of CGG (cytosine-guanine-guanine) repeats at Xq27.3
[4,5]. The number of repeats and the degree of methy-
lation determine whether or not an individual is affected:
2–49 repeats (mean, 30) is phenotypically normal; 50–
199 repeats is called premutation, and such individuals
do not usually exhibit overt clinical symptoms related
to the mutation; and at least 200 repeats is called full
mutation. Methylation of the CGG repeats and the
surrounding promoter region inhibits FMR1 trans-
cription and causes the absence of the RNA binding
protein product. Of males with full mutation, 80% ex-
press mental retardation, with an intelligence quotient
(IQ) of less than 30–45, while of females with full muta-
tion, 50–70% have mental retardation with an IQ of
75–85 [1]. The most impressive somatic involvement
that is consistently found among only premutated carrier
females, not full-mutation carriers, is premature ovarian
failure (POF). Of female premutated carriers, 20–28%
have POF, whereas only 14% of full-mutation carriers
and 6% of non-carriers have POF [1,6–8]. By convention,
menopause that occurs between 40 and 45 years of
age is considered early menopause and occurs in about
3–5% of women [9]. POF, defined as loss of ovarian fol-
licles before 40 years of age, accounts for approximately
1% of the population [7,10]. The etiologies of POF are
chromosomal anomalies, autoimmune diseases, meta-
bolic diseases, familial heritance, infection, iatrogenic
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induction, and idiopathic cause. The common chromo-
somal anomalies causing impaired ovarian function are
Turner syndrome (45X), 47XXX, and fragile X syndrome.
Case Report
A 31-year-old female visited our gynecology depart-
ment with the chief complaint of menopause at the age
of 23. Her two older sisters had experienced the same
condition, with menopause in their early thirties. One
of her sisters had married and had a boy with mental
retardation (IQ, 50). The boy had been diagnosed with
fragile X syndrome with more than 200 CGG repeats.
The patient and her sisters were diagnosed to be
premutated carriers, with 80–100 CGG repeats. The
pedigree is shown in Figure 1. The patient’s father had
another family in mainland China and the family had
the same situation: all females had POF and one of the
three sisters had a son with mental retardation (unknown
IQ). It appeared that these female cases had all been
affected by premutation of CGG repeats.
Discussion
What happens in the X chromosomes, and how can
we give a reasonable explanation of POF in premutated
fragile X carriers? Murray et al consider that an FMR1
isoform could be inappropriately expressed in the
fetal ovaries of premutated females [11]. But this does
not explain the lower incidence of POF in females with
full-mutation fragile X. We reviewed recent reports and
gathered five main hypotheses. First, ovarian dysgene-
sis develops in Turner syndrome and X monosomy
(45X). A double dose of the ovarian development gene
is necessary for normal ovarian development, and this
gene(s) escapes X-inactivation [9]. Second, molecular
studies of ovarian dysfunction and Xq abnormalities
from the last 10 years show that breakpoints are proxi-
mal at Xq13.3–q21.3 and Xq21.3–q22 and distal at
Xq26–q28 [9,12]. The most common fragile X syndrome
mutation is amplification of CGG repeats in the first
exon of the FMR1 gene at Xq27.3. The premutation may
affect a nearby gene(s) for ovarian function, inducing
abnormal methylation so that fewer oocytes develop.
Third, Sun et al reported non-random X inactivation
and selection of fragile X full mutation in female fetal
fibroblasts [13]. Fourth, an increase in twinning rates
in premutated carriers has been observed by many
investigators [6,14,15]. Partington et al suggested that
fragile X carriers may produce fewer eggs, leading
to premature menopause and an increased rate of
dizygous twinning at an earlier age than usual; excess
dizygous twinning could reflect a programmed excess
hypothalamic stimulation of the ovaries resulting in
excess follicular usage and earlier menopause [6,14–
16]. Fifth, endocrine profiles performed by Braat et al
show abnormal serum follicle-stimulating hormone
elevation on cycle day 1–2 in two of five premutated
carriers [17].
From these five hypotheses, we suggest a possible
mechanism, initiated by randomized and non-
randomized selection of X chromosome activation in
premutated fragile X carriers and full mutation cases
(Figures 2 and 3). Figure 4 shows a flow chart of this
mechanism of POF in premutated fragile X carriers
after randomized X chromosome activation selection.
Finally, we used these five hypotheses to conclude that
randomized selection of X chromosome activation in
premutated fragile X carriers may lead to fewer oocytes
and excess follicular usage, causing POF in fragile
premutated carriers. Clinically, what can we do for
females and their families affected by fragile X syn-
Figure 1. Pedigree of familial premature ovarian failure (POF). POF developed in all six daughters and fragile X was transmitted
to two males.
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Figure 4. Hypothetical mechanism for premature ovarian
failure (POF) in premutated female fragile X carriers after
randomized selection of X chromosome activation (active
selection of premutated X chromosome).
Figure 2. Randomized selection of X chromosome activation in premutated fragile X carriers. Black bands, Xq13.3–21.3 and
Xq26–28, represent ovarian function gene domain and promoter gene for ovarian function regulation separately.
Figure 3. Non-randomized inactivation selection of X chromosome in full-mutation fragile X syndrome carriers and non-
carriers.
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drome, especially premutated carriers? It is important
to provide prenatal counseling and prenatal diagnosis,
to assist them in making reproductive decisions, and
to take care of health issues (risk for osteoporosis due
to POF and other complications of the menopause).
Modern artificial reproductive techniques, such as frozen
preservation of ovarian tissue or oocyte donation and
hormonal therapy, may play a role [18]. Clinically,
female carriers of fragile X premutations have no
increased risk for additional diseases other than POF
[19]. More research is needed to prove our hypothesis
and discover the gene(s) that regulate normal ovarian
function to avoid POF.
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